A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (öffnet neues Fenster)

Basta MN, Stricker PA, Taylor JA.

Quelle‎: Pediatr Surg Int 2012;28(11):1059-69.

Indiziert‎: PubMed 22940882

DOI‎: 10.1007/s00383-012-3167-6

https://www.ncbi.nlm.nih.gov/pubmed/22940882 (öffnet neues Fenster)

Use of tranexamic acid as a rescue measure to achieve hemostasis after massive blood loss in a pediatric neurosurgical patient. (öffnet neues Fenster)

Bharath K, Bhagat H, Mohindra S.

Quelle‎: J Neurosurg Anesthesiol 2011;23(4):376-7.

Indiziert‎: PubMed 21876453

DOI‎: 10.1097/ANA.0b013e31822c804f

https://www.ncbi.nlm.nih.gov/pubmed/21876453 (öffnet neues Fenster)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (öffnet neues Fenster)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

Quelle‎: Br J Anaesth 2012;108(5):830-7.

Indiziert‎: PubMed 22362670

DOI‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (öffnet neues Fenster)

A Jehovah's Witness child with hemophilia B and factor IX inhibitors undergoing scoliosis surgery. [Chirurgie de la scoliose chez un enfant Témoin de Jéhovah souffrant d’hémophilie B et présentant des inhibiteurs du facteur IX.] [English, French abstract] (öffnet neues Fenster)

Chau A, Wu J, Ansermino M, Tredwell S, Purdy R.

Quelle‎: Can J Anaesth 2008;55(1):47-51.

Indiziert‎: PubMed 18166748

DOI‎: 10.1007/BF03017597

https://www.ncbi.nlm.nih.gov/pubmed/18166748 (öffnet neues Fenster)

Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. (öffnet neues Fenster)

Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A.

Quelle‎: Spine (Phila Pa 1976) 2008;33(24):2577-80.

Indiziert‎: PubMed 19011538

DOI‎: 10.1097/BRS.0b013e318188b9c5

https://www.ncbi.nlm.nih.gov/pubmed/19011538 (öffnet neues Fenster)

The efficacy of antifibrinolytic drugs in children undergoing noncardiac surgery: a systematic review of the literature. (öffnet neues Fenster)

Faraoni D, Goobie SM.

Quelle‎: Anesth Analg 2014;118(3):628-36.

Indiziert‎: PubMed 24557107

DOI‎: 10.1213/ANE.0000000000000080

https://www.ncbi.nlm.nih.gov/pubmed/24557107 (öffnet neues Fenster)

The effect of Amicar on perioperative blood loss in idiopathic scoliosis: the results of a prospective, randomized double-blind study. (öffnet neues Fenster)

Florentino-Pineda I, Thompson GH, Poe-Kochert C, Huang RP, Haber LL, Blakemore LC.

Quelle‎: Spine 2004;29(3):233-8.

Indiziert‎: PubMed 14752343

https://www.ncbi.nlm.nih.gov/pubmed/14752343 (öffnet neues Fenster)

A randomized control trial to verify the efficacy of pre-operative intravenous tranexamic acid in the control of tonsillectomy bleeding. (öffnet neues Fenster)

George A, Kumar R, Kumar S, Shetty S.

Quelle‎: Indian J Otolaryngol Head Neck Surg 2011;63(1):20-6.

Indiziert‎: PubMed 22319712

DOI‎: 10.1007/s12070-010-0095-4

https://www.ncbi.nlm.nih.gov/pubmed/22319712 (öffnet neues Fenster)

Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial. (öffnet neues Fenster)

Goobie SM, Meier PM, Pereira LM, McGowan FX, Prescilla RP, Scharp LA, Rogers GF, Proctor MR, Meara JG, Soriano SG, Zurakowski D, Sethna NF.

Quelle‎: Anesthesiology 2011;114(4):862-71.

Indiziert‎: PubMed 21364458

DOI‎: 10.1097/ALN.0b013e318210fd8f

https://www.ncbi.nlm.nih.gov/pubmed/21364458 (öffnet neues Fenster)

Tranexamic acid is efficacious at decreasing the rate of blood loss in adolescent scoliosis surgery: a randomized placebo-controlled trial. (öffnet neues Fenster)

Goobie SM, Zurakowski D, Glotzbecker MP, McCann ME, Hedequist D, Brustowicz RM, Sethna NF, Karlin LI, Emans JB, Hresko MT

Quelle‎: J Bone Joint Surg Am 2018;100(23):2024-32.

Indiziert‎: PubMed 30516625

DOI‎: 10.2106/JBJS.18.00314

https://www.ncbi.nlm.nih.gov/pubmed/30516625 (öffnet neues Fenster)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (öffnet neues Fenster)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Quelle‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

Indiziert‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (öffnet neues Fenster)

Anesthetic management for transfusion-free Rastelli's procedure in a pediatric Jehovah's Witness patient. (öffnet neues Fenster)

Kang SH, Song I, Kang JE, Lee JH, Kim JT.

Quelle‎: Korean J Anesthesiol 2013;65(6 Suppl):S87-8.

Indiziert‎: PubMed 24478887

DOI‎: 10.4097/kjae.2013.65.6S.S87

https://www.ncbi.nlm.nih.gov/pubmed/24478887 (öffnet neues Fenster)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (öffnet neues Fenster)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Quelle‎: PLoS One 2015;10(5):e0126514.

Indiziert‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (öffnet neues Fenster)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (öffnet neues Fenster)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Quelle‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

Indiziert‎: PubMed 21115357

DOI‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (öffnet neues Fenster)

Antifibrinolytic agents reduce blood loss during pediatric vertebral column resection procedures. (öffnet neues Fenster)

Newton PO, Bastrom TP, Emans JB, Shah SA, Shufflebarger HL, Sponseller PD, Sucato DJ, Lenke LG.

Quelle‎: Spine (Phila Pa 1976) 2012;37(23):E1459-63.

Indiziert‎: PubMed 22872217

DOI‎: 10.1097/BRS.0b013e31826c9fe4

https://www.ncbi.nlm.nih.gov/pubmed/22872217 (öffnet neues Fenster)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (öffnet neues Fenster)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Quelle‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indiziert‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (öffnet neues Fenster)

Use of tranexamic acid in infants undergoing choroid plexus papilloma surgery: a report of two cases. (öffnet neues Fenster)

Phi JH, Goobie SM, Hong KH, Dholakia A, Smith ER.

Quelle‎: Paediatr Anaesth 2014;24(7):791-3.

Indiziert‎: PubMed 24924340

DOI‎: 10.1111/pan.12447

https://www.ncbi.nlm.nih.gov/pubmed/24924340 (öffnet neues Fenster)

The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis. (öffnet neues Fenster)

Schouten ES, van de Pol AC, Schouten AN, Turner NM, Jansen NJ, Bollen CW.

Quelle‎: Pediatr Crit Care Med 2009;10(2):182-90.

Indiziert‎: PubMed 19188875

DOI‎: 10.1097/PCC.0b013e3181956d61

https://www.ncbi.nlm.nih.gov/pubmed/19188875 (öffnet neues Fenster)

The role of Amicar in same-day anterior and posterior spinal fusion for idiopathic scoliosis. (öffnet neues Fenster)

Thompson GH, Florentino-Pineda I, Poe-Kochert C, Armstrong DG, Son-Hing JP.

Quelle‎: Spine (Phila Pa 1976) 2008;33(20):2237-42.

Indiziert‎: PubMed 18794767

DOI‎: 10.1097/BRS.0b013e31817bd889

https://www.ncbi.nlm.nih.gov/pubmed/18794767 (öffnet neues Fenster)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (öffnet neues Fenster)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

Quelle‎: Ann Card Anaesth 2010;13(2):110-5.

Indiziert‎: PubMed 20442540

DOI‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (öffnet neues Fenster)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (öffnet neues Fenster)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

Quelle‎: Anesthesiology 2015;122(4):746-58.

Indiziert‎: PubMed 25585004

DOI‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (öffnet neues Fenster)

Does the intraoperative tranexamic acid decrease operative blood loss during posterior spinal fusion for treatment of adolescent idiopathic scoliosis? (öffnet neues Fenster)

Yagi M, Hasegawa J, Nagoshi N, Iizuka S, Kaneko S, Fukuda K, Takemitsu M, Shioda M, Machida M.

Quelle‎: Spine (Phila Pa 1976) 2012;37(21):E1336-42.

Indiziert‎: PubMed 22772572

DOI‎: 10.1097/BRS.0b013e318266b6e5

https://www.ncbi.nlm.nih.gov/pubmed/22772572 (öffnet neues Fenster)

Pediatric off-label use of recombinant factor VIIa. (öffnet neues Fenster)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Quelle‎: Pediatrics 2009;123(3):1066-72.

Indiziert‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (öffnet neues Fenster)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (öffnet neues Fenster)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

Quelle‎: Indian J Pediatr 2011;78(8):961-8.

Indiziert‎: PubMed 21328080

DOI‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (öffnet neues Fenster)

Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (öffnet neues Fenster)

Brady KM, Easley RB, Tobias JD.

Quelle‎: Paediatr Anaesth 2006;16(10):1042-6.

Indiziert‎: PubMed 16972833

DOI‎: 10.1111/j.1460-9592.2006.02039.x

https://www.ncbi.nlm.nih.gov/pubmed/16972833 (öffnet neues Fenster)

A Jehovah's Witness child with hemophilia B and factor IX inhibitors undergoing scoliosis surgery. [Chirurgie de la scoliose chez un enfant Témoin de Jéhovah souffrant d’hémophilie B et présentant des inhibiteurs du facteur IX.] [English, French abstract] (öffnet neues Fenster)

Chau A, Wu J, Ansermino M, Tredwell S, Purdy R.

Quelle‎: Can J Anaesth 2008;55(1):47-51.

Indiziert‎: PubMed 18166748

DOI‎: 10.1007/BF03017597

https://www.ncbi.nlm.nih.gov/pubmed/18166748 (öffnet neues Fenster)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (öffnet neues Fenster)

Guzzetta NA, Russell IA, Williams GD.

Quelle‎: Anesth Analg 2012;115(2):364-78.

Indiziert‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (öffnet neues Fenster)

The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. A systematic review. (öffnet neues Fenster)

Mathew P.

Quelle‎: Thromb Haemost 2004;92(4):738-46.

Indiziert‎: PubMed 15467904

DOI‎: 10.1160/TH04-03-0163

https://www.ncbi.nlm.nih.gov/pubmed/15467904 (öffnet neues Fenster)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (öffnet neues Fenster)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Quelle‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

Indiziert‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (öffnet neues Fenster)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (öffnet neues Fenster)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Quelle‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

Indiziert‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (öffnet neues Fenster)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (öffnet neues Fenster)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Quelle‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Indiziert‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (öffnet neues Fenster)

Off-label use of rFVIIa in children with excessive bleeding: a consecutive study of 153 off-label uses in 139 children. (öffnet neues Fenster)

Young G, Wicklund B, Neff P, Johnson C, Nugent DJ.

Quelle‎: Pediatr Blood Cancer 2009;53(2):179-83.

Indiziert‎: PubMed 19415741

DOI‎: 10.1002/pbc.22053

https://www.ncbi.nlm.nih.gov/pubmed/19415741 (öffnet neues Fenster)

Emergent pediatric anticoagulation reversal using a 4-factor prothrombin complex concentrate. (öffnet neues Fenster)

Adams CB, Vollman KE, Leventhal EL, Acquisto NM.

Quelle‎: Am J Emerg Med 2016;34(6):1182.e1-2.

Indiziert‎: PubMed 26652577

DOI‎: 10.1016/j.ajem.2015.10.041

https://www.ncbi.nlm.nih.gov/pubmed/26652577 (öffnet neues Fenster)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (öffnet neues Fenster)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Quelle‎: Artif Organs 2010;34(11):955-60.

Indiziert‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (öffnet neues Fenster)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (öffnet neues Fenster)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

Quelle‎: Eur J Anaesthesiol 2014;31(6):317-26.

Indiziert‎: PubMed 24503704

DOI‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (öffnet neues Fenster)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (öffnet neues Fenster)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Quelle‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

Indiziert‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (öffnet neues Fenster)

Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (öffnet neues Fenster)

Noga T, Bruce AA, Blain H, Nahirniak S.

Quelle‎: Vox Sang 2016;110(3):253-7.

Indiziert‎: PubMed 26509839

DOI‎: 10.1111/vox.12353

https://www.ncbi.nlm.nih.gov/pubmed/26509839 (öffnet neues Fenster)

Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. (öffnet neues Fenster)

Macksey LF, White B.

Quelle‎: AANA J 2007;75(4):261-4.

Indiziert‎: PubMed 17711156

https://www.ncbi.nlm.nih.gov/pubmed/17711156 (öffnet neues Fenster)

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (öffnet neues Fenster)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

Quelle‎: Ann Card Anaesth 2012;15(1):26-31.

Indiziert‎: PubMed 22234018

DOI‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (öffnet neues Fenster)

Perioperative bleeding management in pediatric patients. (öffnet neues Fenster)

Goobie SM, Haas T.

Quelle‎: Curr Opin Anaesthesiol 2016;29(3):352-8.

Indiziert‎: PubMed 26844864

DOI‎: 10.1097/ACO.0000000000000308

https://www.ncbi.nlm.nih.gov/pubmed/26844864 (öffnet neues Fenster)

Management of dilutional coagulopathy during pediatric major surgery. (öffnet neues Fenster)

Haas T, Mauch J, Weiss M, Schmugge M.

Quelle‎: Transfus Med Hemother 2012;39(2):114-9.

Indiziert‎: PubMed 22670129

DOI‎: 10.1159/000337245

https://www.ncbi.nlm.nih.gov/pubmed/22670129 (öffnet neues Fenster)

Higher fibrinogen concentrations for reduction of transfusion requirements during major paediatric surgery: a prospective randomised controlled trial. (öffnet neues Fenster)

Haas T, Spielmann N, Restin T, Seifert B, Henze G, Obwegeser J, Min K, Jeszenszky D, Weiss M, Schmugge M.

Quelle‎: Br J Anaesth 2015;115(2):234-43.

Indiziert‎: PubMed 25982134

DOI‎: 10.1093/bja/aev136

https://www.ncbi.nlm.nih.gov/pubmed/25982134 (öffnet neues Fenster)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (öffnet neues Fenster)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

Quelle‎: Br J Anaesth 2015;114(1):91-102.

Indiziert‎: PubMed 25303988

DOI‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (öffnet neues Fenster)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (öffnet neues Fenster)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Quelle‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

Indiziert‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (öffnet neues Fenster)

Activated coagulation time vs. intrinsically activated modified rotational thromboelastometry in assessment of hemostatic disturbances and blood loss after protamine administration in elective cardiac surgery: analysis from the clinical trial (NCT01281397). (öffnet neues Fenster)

Petricevic M, Biocina B, Milicic D, Svetina L, Boban M, Lekić A, Konosic S, Milosevic M, Gasparovic H.

Quelle‎: J Cardiothorac Surg 2014;9:129.

Indiziert‎: PubMed 25231271

DOI‎: 10.1186/1749-8090-9-129

https://www.ncbi.nlm.nih.gov/pubmed/25231271 (öffnet neues Fenster)